Cytokine signal transduction in P19 embryonal carcinoma cells: Regulation of Stat3-mediated transactivation occurs independently of p21ras- Erk signaling

Experimental Cell Research

Volumn 251, Issue 2, 1999, Pages 465-476

  Van Puijenbroek, André A F L ^a   Van Der Saag, Paul T ^a   Coffer, Paul J ^b  

^a HUBRECHT INSTITUTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CNTF; ERK; LIF; P19; RAS; STAT

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIUM ION; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; EMBRYO; EMBRYONAL CARCINOMA; ENZYME ACTIVATION; ENZYME ACTIVITY; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALIA;

EID: 0033568320     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4576     Document Type: Article

References (68)

1. Taga T., Kishimoto T. Cytokine receptors and signal transduction. FASEB J. 6:1992;3387-3396.
2. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood. 86:1995;1243-1254.
3. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell. 76:1994;253-262.
4. Stahl N., Yancopoulos G. D. The tripartite CNTF receptor complex: Activation and signaling involves components shared with other cytokines. J. Neurobiol. 25:1994;1454-1466.
5. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 260:1993;1808-1810.
6. Hilton D. J., Hilton A. A., Raicevic A., Rakar S., Harrison-Smith M., Gough N. M., Begley C. G., Metcalf D., Nicola N. A., Willson T. A. Cloning of a murine IL-11 receptor alpha-chain: Requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13:1994;4765-4775.
7. Davis S., Aldrich T. H., Stahl N., Pan L., Taga T., Kishimoto T., Ip N. Y., Yancopoulos G. D. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science. 260:1993;1805-1807.
8. Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B., Ziegler S. F., Cosman D. The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor. Science. 255:1992;1434-1437.
9. Pennica D., Shaw K. J., Swanson T. A., Moore M. W., Shelton D. L., Zioncheck K. A., Rosenthal A., Taga T., Paoni N. F., Wood W. I. Cardiotrophin-1: Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 270:1995;10915-10922.
10. Schindler C., Darnell J. E. Jr. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu. Rev. Biochem. 64:1995;621-651.
11. Lütticken C., Wegenka U. M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A. G., Wilks A. F., Yasukawa K., Taga S., Kishimoto T., Barbieri G., Pellgrini S., Sendtner M., Heinrich P. C., Horn F. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science. 263:1994;89-92.
12. Stahl N., Boulton T. G., Farrugella T., Ip N. Y., Davis S., Witthuhn B. A., Quelle F. W., Silvennoinen O., Barbieri G., Pellegrini S., Ihle J. N., Yancopoulos G. D. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science. 263:1994;92-95.
13. Stahl N., Farruggella J., Boulton T. G., Zhong Z., Darnell J. E. Jr., Yancopoulos G. D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science. 267:1995;1349-1353.
14. Ihle J. N. Cytokine receptor signaling. Nature. 377:1995;591-594.
15. Ihle J. N. STATs: Signal transducers and activators of transcription. Cell. 84:1996;331-334.
16. Ihle J. N., Kerr I. M. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:1995;69-74.
17. Boulton T. G., Zhong Z., Wen Z., Darnell J. E., Stahl N., Yancopoulos G. D. Stat3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA. 92:1995;6915-6919.
18. Lütticken C., Coffer P., Yuan J., Schwartz C., Caldenhoven E., Schindler C., Kruijer W., Heinrich P. C., Horn F. Interleukin-6-induced serine phosphorylation of transcription factor APRF: Evidence for a role in interleukin-6 target gene induction. FEBS Lett. 360:1995;137-143.
19. Wen Z., Zhong Z., Darnell J. E. Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250.
20. Zhang X., Blenis J., Li H.-C., Schindler C., Chen-Kiang S. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science. 267:1995;1990-1994.
21. Ihle J. N. STATs and MAPKs: Obligate or opportunistic partners in signaling. BioEssays. 18:1996;95-98.
22. Martin G. R. Teratocarcinomas and mammalian embryogenesis. Science. 209:1980;768-775.
23. McBurney M. W., Rogers B. J. Isolation of male embryonal carcinoma cells and their chromosome replication patterns. Dev. Biol. 89:1982;503-508.
24. McBurney M. W. P19 embryonal carcinoma cells. Int. J. Dev. Biol. 37:1993;135-140.
25. Bain G., Ray W. J., Yao M., Gotlieb D. I. From embryonal carcinoma cells to neurons: The P19 pathway. Bioassays. 16:1994;343-348.
26. Gupta S. K., Haggarty A. J., Carbonetto S., Riopelle R. J., Richardson P. M., Dunn R. J. Trophic actions of ciliary neurotrophic factor on murine embryonic carcinoma cells. Eur. J. Neurosci. 5:1993;977-985.
27. Luckow B., Schutz G. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:1987;5490.
28. van Zonneveld A. J., Curriden A. J., Loskutoff D. J. Type 1 plasminogen activator inhibitor gene: Functional analysis and glucocorticoid regulation of its promoter. Proc. Natl. Acad. Sci. USA. 85:1988;5525-5529.
29. Coffer P., Lutticken C., van Puijenbroek A., Klop-de Jonge M., Horn F., Kruijer W. Transcriptional regulation of the junB promoter: Analysis of STAT-mediated signal transduction. Oncogene. 10:1995;985-994.
30. Shen S., van der Saag P. T., Kruijer W. Dominant negative retinoic acid receptor beta. Mech. Dev. 40:1993;177-189.
31. Caldenhoven E., Coffer P., Yuan J., van de Stolpe A., Horn F., Kruijer W., van der Saag P. T. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. J. Biol. Chem. 269:1994;21146-21154.
32. Burgering B. M. Th., Coffer P. J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:1995;599-602.
33. den Hertog J., de Laat S. W., Schlessinger J., Kruijer W. Neuronal differentiation in response to epidermal growth factor of transfected murine P19 embryonal carcinoma cells expressing human epidermal growth factor receptors. Cell Growth Differ. 2:1991;155-164.
34. Graham F. L., van der Eb A. J. Mol. Cell. Biol. 2:1973;607-616.
35. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
36. Pfahl M., Tzukerman M., Zhang X-K., Lehmann J. M., Hernann T., Wills K. N., Graupner G. Nuclear retinoic acid receptors: Cloning, analysis, and function. Methods Enzymol. 189:1990;256-270.
37. Brasier A. R., Tate J. E., Habener J. F. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques. 7:1989;1116-1122.
38. Andrews N. C., Faller D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:1991;2499.
39. de Vries-Smits A. M. M., Burgering B. M. T., Leevers S. J., Marshall C. J., Bos J. L. Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature. 357:1992;602-604.
40. Horvath C. M., Wen Z., Darnell J. E. Jr. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9:1995;984-994.
41. Bonni A., Frank D. A., Schindler C., Greenberg M. E. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus. Science. 262:1993;1575-1579.
42. Symes A., Lewis S., Corpus L., Rajan P., Hyman S. E., Fink J. S. STAT proteins participate in the regulation of the vasoactive intestinal peptide gene by the ciliary neurotrophic factor family of cytokines. Mol. Endocrinol. 8:1994;1750-1763.
43. van de Stolpe A., Caldenhoven E., Stade B. G., Koenderman L., Raaijmakers J. A. M., Johnson J. P., van der Saag P. T. 12-O-Tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone: Functional analysis of the intercellular adhesion molecule-1 promoter. J. Biol. Chem. 269:1994;6185-6192.
44. Lord K. A., Abdollahi A., Thomas S. M., DeMarco M., Brugge J. S., Hoffman-Liebermann B., Liebermann D. A. Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation. Mol. Cell. Biol. 11:1991;4371-4379.
45. Nakajima K., Wall R. Interleukin-6 signals activating junB and TIS11 gene transcription in a B-cell hybridoma. Mol. Cell. Biol. 11:1991;1409-1418.
46. David M., Petricoin E. III, Benjamin C., Pine R., Weber M. J., Larner A. C. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science. 269:1995;1721-1723.
47. Allessi D. R., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
48. Dudley D. T., Pang L., Decker S. J., Bridges A. J., Saltiel A. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1995;7686-7689.
49. Conover J. C., Ip N. Y., Poueymirou W. T., Bates B., Goldfarb M. P., DeChiara T. M., Yancopoulos G. D. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development. 119:1993;559-565.
50. Hocke G. M., Cui M-Z., Fey G. H. The LIF response element of the alpha 2 macroplobulin gene confers LIF-induced transcriptional activation in embryonal stem cells. Cytokine. 7:1995;491-502.
51. Starr R., Hilton D. J. Negative regulation of the JAK/STAT pathway. BioEssays. 21:1999;47-52.
52. Yoshimura A. The CIS/JAB family: Novel negative regulators of JAK signaling pathways. Leukemia. 12:1998;1851-1857.
53. Symes A., Stahl N., Reeves S. A., Farruggella T., Servidei T., Gearan T., Yancopoulos G. D., Fink J. S. Curr. Biol. 7:1997;697-700.
54. Chung C. D., Liao L., Liu B., Rao X., Jay P., Berta P., Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science. 278:1997;1803-1805.
55. Dittrich E., Rose-John S., Gerhartz C., Müllberg J., Stoyan T., Yasukawa K., Heinrich P. C., Graeve L. Identification of a region within the cytoplasmic domain of the interleukin-6 (IL-6) signal transducer gp130 important for ligand-induced endocytosis of the IL-6 receptor. J. Biol. Chem. 269:1994;19014-19020.
56. Wang Y., Fuller G. M. Phosphorylation and internalization of gp130 occur after IL-6 activation of Jak2 kinase in hepatocytes. Mol. Biol. Cell. 5:1994;819-828.
57. Boulton T. G., Stahl N., Yancopoulos G. D. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem. 269:1994;11648-11655.
58. Pawson T. Protein modules and signaling networks. Nature. 373:1995;573-580.
59. Hill C. S., Treisman R. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell. 80:1995;199-211.
60. Nakajima T., Kinoshita S., Sasagawa T., Sasaki K., Naruto M., Kishimoto T., Akira S. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL-6. Proc. Natl. Acad. Sci. USA. 90:1993;2207-2211.
61. Silvennoinen O., Schindler C., Schlessinger J., Levy D. E. Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science. 261:1993;1736-1739.
62. Muller M., Laxton C., Briscoe J., Schindler C., Improta T., Darnell J. E., Stark G. R., Kerr I. M. Complementation of a mutant cell line: Central role of the p91kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 12:1993;4221-4228.
63. Chung J., Uchida E., Grammer T. C., Blenis J. Stat3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosinephosphorylation. Mol. Cell. Biol. 17:1997;6508-6516.
64. Coffer P. J., van Puijenbroek A. A. F. L., Burgering B. M., Klop-de Jonge M., Koenderman L., Bos J. L., Kruijer W. Insulin activates Stat3 independently of p21ras-ERK and PI-3K signal transduction. Oncogene. 20:1997;2529-2539.
65. Beadling C., Ng J., Babbage J. W., Cantrell D. A. Interleukin-2 activation of Stat5 requires the convergent activation of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 15:1996;1902-1913.
66. Zhu X., Wen Z., Xu L. Z., Darnell J. E. Jr. Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol. Cell. Biol. 17:1997;6618-6623.
67. Jain N., Zhang T., Fong S. L., Lim C. P., Cao X. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene. 17:1998;3157-3167.
68. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA. 94:1997;3801-3804.